Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chromocell Therapeutics Corp (NY: CHRO )

1.270 +0.020 (+1.60%)
Official Closing Price Updated: 8:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,087
Open 1.270
Bid (Size) 1.220 (1)
Ask (Size) 1.300 (2)
Prev. Close 1.250
Today's Range 1.260 - 1.280
52wk Range 1.210 - 6.000
Shares Outstanding 23,083,169,588
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q1 2024
Chromocell Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-73.54%
-73.54%
1 Month
-5.22%
-5.22%
3 Month
-47.08%
-47.08%
6 Month
-73.54%
-73.54%
1 Year
-73.54%
-73.54%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Ride-Hailing Startup Ryde Makes Public Debut
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.